First Middle East Transcatheter Aortic Valve Implantation (Tavi) Experience: Immediate and 18 Months Follow-Up.

Elwatidy, Ahmed M.; Hassan, Walid; S, Kassab; Ahmari, Saeed Al; Alsergani, Hani; Alamri, Hussein; Bukhari, Emad; Shahid, Maie; Al-Halees, Zuhair

doi:10.1016/s0735-1097(11)61350-8

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We were first to start TAVI in the Middle East and Gulf region in 2008 as an alternative method to surgical AV replacement to many patients with severe calcific AS who have very high risk or prohibitive surgical risks [17,18]. Currently, we refined our approach to use only conscious sedation, local anesthesia, transthoracic echocardiography (no general anesthesia, no intubation hence reducing the procedure time and complications).…”

Section: Discussionmentioning

confidence: 99%

Improvement of angiodysplasia-derived anemia after transcatheter aortic valve implantation: A case report and literature review

Hassan¹,

Lhmdi²,

Hassan³

et al. 2016

Hypertens Curr Concepts Ther

Self Cite

View full text Add to dashboard Cite

Case summary: Aortic stenosis has been associated with anemia due to bleeding episodes from gastrointestinal angiodysplasia. It had been reported that surgical aortic valve replacement corrects the bleeding from angiodysplasia and the associated anemia. In this report, we present a case of a 79 years old female patient with angiodysplasia-derived anemia improved after transcatheter aortic valve implantation.

show abstract

Section: Discussionmentioning

confidence: 99%

Improvement of angiodysplasia-derived anemia after transcatheter aortic valve implantation: A case report and literature review

Hassan¹,

Lhmdi²,

Hassan³

et al. 2016

Hypertens Curr Concepts Ther

Self Cite

View full text Add to dashboard Cite

show abstract

“…There has only been a smattering of publications addressing anaesthesia for TAVI and any numbers, where reported, are small. On the other hand there have been several publications of large trials and national registry data for TAVI [4–9]. Only the paper by Tamburino et al.…”

Section: Lessons From Tavimentioning

confidence: 99%

Sedation vs general anaesthesia for the ‘high‐risk’ patient – what can TAVI teach us?

Hutchinson

2011

Anaesthesia

View full text Add to dashboard Cite

“…In Asia, Singapore started the TAVI program in 2009. In the Middle East and nearby areas, Turkey was the first country to start TAVI program [ 8 ] followed by Iran and Saudi Arabia in 2010 [ 9 , 10 ]. In developing countries, cost-effective treatment is important and in high-risk patients, SAVR is still cost-effective.…”

Section: Introductionmentioning

confidence: 99%

Pakistan Following Foot Prints of Developed World in Structural Interventions: Experience of Transcatheter Aortic Valve Implantation Reported First Time

Ammar

Rizvi

Saghir

et al. 2020

Cureus

View full text Add to dashboard Cite

Background The aim of this study was to evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) program in a Tertiary care hospital in Karachi, Pakistan. Methodology This study was conducted by interventional cardiology department of the National Institute of Cardiovascular Diseases (NICVD), Karachi from July 2015 to February 2020. All patients of severe aortic stenosis (AS) who underwent TAVI were included. Baseline characteristics, in-hospital course and one-month follow-up data were collected. Results This study included 100 consecutive patients with severe AS undergoing TAVI. Sixty-three (63.0%) patients were males and the mean age was 67.38 ± 10.73 years. Eighty-five (85%) patients were in the New York Heart Association (NYHA) class III-IV. Aortic valve mean gradient was 51.33±10.47 mmHg and 50% of patients had bicuspid aortic valves. Core valve was implanted in 86 (86%) and evolute-R aortic valve was implanted in 14 (14%) patients. TAVI was successfully done in 94% of patients. Post-deployment aortic valve mean gradient was 5.33±4.13 mmHg. Major vascular access site complications were noted in 14% and atrioventricular (AV) blocks were seen in 22% of cases. There was a significant difference in symptoms of patients before and after the procedure. Overall, eight (8%) patients expired during hospital stay. At one-month follow-up, 76% of patients were found to have no limitation of physical activities. Conclusions Results of this study showed that TAVI is a safe procedure in these high-risk patients and is an alternative to surgery for AS patients in the region.

show abstract

First Middle East Transcatheter Aortic Valve Implantation (Tavi) Experience: Immediate and 18 Months Follow-Up.

Cited by 3 publications

References 0 publications

Improvement of angiodysplasia-derived anemia after transcatheter aortic valve implantation: A case report and literature review

Improvement of angiodysplasia-derived anemia after transcatheter aortic valve implantation: A case report and literature review

Sedation vs general anaesthesia for the ‘high‐risk’ patient – what can TAVI teach us?

Pakistan Following Foot Prints of Developed World in Structural Interventions: Experience of Transcatheter Aortic Valve Implantation Reported First Time

Contact Info

Product

Resources

About